Navigating gastrointestinal challenges in genetic myopathies: Diagnostic insights and future directions

doi:10.5662/wjm.v15.i4.102408

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (677)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-7) series.

Item

Count

PDF

HTML

402

Figures (1-3)

Tables (1-7)

Sum=589

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=71

Dec 20, 2025 (publication date) through Aug 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Methodol. Dec 20, 2025; 15(4): 102408
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.102408

Open in New Tab Full Size Figure Download Figure

Figure 1 The flow chart of the included studies.

Open in New Tab Full Size Figure Download Figure

Figure 2 Diagnostic approaches for gastrointestinal manifestations in genetic myopathies. CT: Computed tomography; BMD: Becker muscular dystrophy; DMD: Duchenne muscular dystrophy; GERD: Gastroesophageal reflux disease; GI: Gastrointestinal; LGMD: Limb-girdle muscular dystrophy; MRI: Magnetic resonance imaging; MtDNA: Mitochondrial DNA; NGS: Next-generation sequencing.

Open in New Tab Full Size Figure Download Figure

Figure 3 Management strategies for gastrointestinal manifestations in genetic myopathies. GERD: Gastroesophageal reflux disease; PPIs: Proton pump inhibitors.

Citation: Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R. Navigating gastrointestinal challenges in genetic myopathies: Diagnostic insights and future directions. World J Methodol 2025; 15(4): 102408
URL: https://www.wjgnet.com/2222-0682/full/v15/i4/102408.htm
DOI: https://dx.doi.org/10.5662/wjm.v15.i4.102408